An article written by Dr. Izumi Sakamoto was published in the 30th issue of PHARM TECH JAPAN (No. 11, p61-64).
An article “Chemically synthesized glycoproteins shed light on novel analytical technologies for biopharmaceuticals” written by Acroscale’s Izumi Sakamoto was published in the 30th issue of PHARM TECH JAPAN. PHARM TECH JAPAN is known for presenting on the latest ideas, cutting-edge technologies and innovationas covering not only drug manufacturing but also the regulatory issues.
Acloscale, Inc. is a wholly owned subsidiary of GlyTech, Inc. and founded in 2014 to develop QC methods for chemically synthesized glycoproteins and the related molecules and offer its analytical services.